ImmVirx
PrivateLast Round
Series B
Jun 5, 2023
Est. Valuation
$49.74M
Total Funding Raised
$48.34M
Company Overview
ImmVirx is a clinical-stage biotechnology company that develops novel oncolytic RNA immunotherapies to treat various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmVirx Comparables
Compare ImmVirx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KaliVir Immunotherapeutics | 84% | |
| TILT Biotherapeutics | 83% | |
| ImmVira | 82% |
ImmVirx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 5, 2023 | ||||
| Series A | Nov 8, 2021 | ||||
| Series A | May 14, 2021 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
ImmVirx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series B |
| Acorn Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2021
Raised $18.5M led by Acorn Capital
ImmVirx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmVirx's valuation, stock price, and market status.
Is ImmVirx a public or private company?
ImmVirx is a private company.
What is the current stock price of ImmVirx?
ImmVirx is a private company with no public stock price. No recent secondary market data is available.
How much is ImmVirx worth (valuation)?
ImmVirx's valuation is estimated at $49.7M based on funding round data.
Can I buy ImmVirx stock?
ImmVirx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmVirx's last funding round?
ImmVirx's most recent funding round was Series B on June 5, 2023.
Who are the main investors in ImmVirx?
Key investors in ImmVirx include OneVentures, Acorn Capital.
Will ImmVirx IPO soon?
No public IPO plans have been announced for ImmVirx.
How can I track ImmVirx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmVirx's secondary market activity and sign up for updates.